CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis

Status:
Completed

Trial end date:
2018-11-01

Target enrollment:

Participant gender:

This is a phase III study to investigate the safety and efficacy of PAC-14028 cream in Atopic Dermatitis patients.

Phase 3

Amorepacific Corporation